Organovo Holdings Founder Calls on Board of Directors to Accept Stockholders’ Opposition to the Illogical Merger With Tarveda Therapeutics

Rather than try to convince stockholders to vote for an illogical transaction with Tarveda, which has limited cash and sparse prospects, the Board of Directors should uphold its duties and finally embrace investor feedback.